Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy

Rush University Medical Center is the first in the country to use the device along with a unique electrode placement planning system

2014-04-22

(Press-News.org) (Chicago) – A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.

That's good news for a large portion of the nearly 400,000 people in the U.S. living with epilepsy whose seizures can't be controlled with medications and who are not candidates for brain surgery.

Epilepsy is a chronic neurological condition characterized by recurrent seizures that disrupt the senses, or can involve short periods of unconsciousness or convulsions. "Many people with epilepsy have scores of unpredictable seizures every day that make it impossible for them to drive, work or even get a good night's sleep," said Dr. Marvin Rossi, co-principal investigator of the NeuroPace Pivotal Clinical Trial and assistant professor of neurology at the Rush Epilepsy Center.

The NeuroPace RNS System uses responsive, or 'on-demand' direct stimulation to detect abnormal electrical activity in the brain and deliver small amounts of electrical stimulation to suppress seizures before they begin.

The device is surgically placed underneath the scalp within the skull and connected to electrodes that are strategically placed within the brain where the seizures originate (called the seizure focus). A programmed computer chip in the skull communicates with the system to record data and to help regulate responsive stimulation.

The unique electrode placement planning modeling system developed at Rush uses a computer-intensive mapping system that facilitates surgical placement of electrodes at the precise location in the brain's temporal lobe circuitry. When stimulated, these extensive epileptic circuits are calmed.

The modeling system predicts where in the brain the activity begins and spreads, so that the device can better influence the maximal extent of the epileptic pathway.

The device also acts as an implanted EEG for recording brain activity. This function was first shown at Rush to help determine whether the patient will further benefit from a surgical resection, in which surgeons remove a portion of the temporal lobe network.

Dr. Richard Byrne, chairman of Neurosurgery at Rush, implants the electrodes in the temporal lobes. As a result, physicians at Rush can offer patients the new implantable neurostimulator device, a surgical resection or both with the possibility of completely eliminating seizures. "This device is also being used at Rush as a foundation and inspiration for building cutting-edge hybrid stimulation therapy-drug molecule delivery systems," said Rossi.

"Devices that treat epilepsy may offer new hope to patients when medication is ineffective and resection is not an option," said Rossi. "Not long ago, it was highly unlikely that these patients would ever be free of their seizures. Now, several of our Rush patients with this device are actually able to drive, lower or even eliminate their medications and aren't as limited as they once were. There is no doubt that quality of life of the majority of our implanted patients is significantly improved."

According to the Centers for Disease Control and Prevention, in 2010, epilepsy affected approximately 2.3 million adults in the U.S. and 467,711 children under the age of 17.

INFORMATION:

About Rush

Rush is a not-for-profit academic medical center comprising Rush University Medical Center, Rush University, Rush Oak Park Hospital and Rush Health. Rush is the only in Illinois and was the first to use this device over the last decade and the only institution to use the mapping system.

ELSE PRESS RELEASES FROM THIS DATE:

Physicists consider implications of recent revelations about the universe's first light

2014-04-22

Last month, scientists announced the first hard evidence for cosmic inflation, the process by which the infant universe swelled from microscopic to cosmic size in an instant. This almost unimaginably fast expansion was first theorized more than three decades ago, yet only now has "smoking gun" proof emerged. What is this result and what does it mean for our understanding of the universe? Late last week, two members of the discovery team discussed the finding and its implications with two of the field's preeminent thought leaders. Walter Ogburn is a postdoctoral researcher ...

Biting vs. chewing

2014-04-22

There's a new secret to get your child to behave at the dinner table—cut up their food and they'll relax. A new Cornell study published in Eating Behaviors, found that when 6-10 year old children ate foods they had to bite with their front teeth— such as drumsticks, whole apples, or corn on the cob— they were rowdier than when these foods had been cut. "They were twice as likely to disobey adults and twice as aggressive toward other kids," said Brian Wansink, Professor and Director of the Cornell Food and Brand Lab. During a 4-H summer camp, 12 elementary children ...

Bioinformatics profiling identifies a new mammalian clock gene

2014-04-22

PHILADELPHIA - Over the last few decades researchers have characterized a set of clock genes that drive daily rhythms of physiology and behavior in all types of species, from flies to humans. Over 15 mammalian clock proteins have been identified, but researchers surmise there are more. A team from the Perelman School of Medicine at the University of Pennsylvania wondered if big-data approaches could find them. To accelerate clock-gene discovery, the investigators, led by John Hogenesch, PhD, professor of Pharmacology and first author Ron Anafi, MD, PhD, an instructor ...

Clinics not bogged down by red tape can ease health cost burdens

2014-04-22

Health clinics that can provide primary care for low-income patients may ease the financial burden on both hospitals and insurance companies while improving patient health, researchers have concluded. A study of hospital admissions suggests that health clinics that avoid costs associated with insurance administration can help hospitals save money by lowering hospital admission rates and emergency room visits, according to Mark Agee, professor of economics, Penn State Altoona. The researchers estimated that the major hospital in the area saved $201,414 annually in lower ...

Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches

2014-04-22

DALLAS – April 22, 2014 – Researchers at UT Southwestern Medical Center are making breakthroughs that could benefit people suffering from depression. A team of physician-scientists at UT Southwestern has identified a major mechanism by which ghrelin (a hormone with natural anti-depressant properties) works inside the brain. Simultaneously, the researchers identified a potentially powerful new treatment for depression in the form of a neuroprotective drug known as P7C3. The study, published online in April's issue of Molecular Psychiatry, is notable because although ...

Scientists pinpoint protein that could improve small cell lung cancer therapies

2014-04-22

Approximately 15 percent of all lung cancers are small cell lung cancers (SCLC), which grow rapidly and often develop resistance to chemotherapy. However, researchers at Virginia Commonwealth University Massey Cancer Center have revealed new insights into the mechanisms leading to this resistance that may lead to improved therapies. Chemotherapies work primarily by mediating B-cell lymphoma 2 (Bcl-2) family proteins, which are responsible for regulating cell death. Depending on their function, this family of proteins can trigger a form of cell suicide known as apoptosis ...

Risk of pregnancy greater with newer method of female sterilization

2014-04-22

(SACRAMENTO, Calif.) — The risk of pregnancy among women using a newer method of planned sterilization called hysteroscopic sterilization is more than 10 times greater over a 10-year period than using the more commonly performed laparoscopic sterilization, a study by researchers at Yale University and UC Davis has found. Published online today in the medical journal Contraception, the study found the higher risk of pregnancy with a newer sterilization method marketed under the brand name Essure®. "This study provides essential information for women and their doctors ...

PETA science consortium to present hazard testing strategy at nanotoxicology meeting

2014-04-22

London – PETA International Science Consortium Ltd.'s nanotechnology expert will present a poster titled "A tiered-testing strategy for nanomaterial hazard assessment" at the 7th International Nanotoxicology Congress to be held April 23-26, 2014, in Antalya, Turkey. Dr. Monita Sharma will outline a strategy consistent with the 2007 report from the US National Academy of Sciences, "Toxicity Testing in the 21st Century: A Vision and a Strategy," which recommends use of non-animal methods involving human cells and cell lines for mechanistic pathway–based toxicity studies. ...

Nanoreporters tell 'sour' oil from 'sweet'

2014-04-22

Scientists at Rice University have created a nanoscale detector that checks for and reports on the presence of hydrogen sulfide in crude oil and natural gas while they're still in the ground. The nanoreporter is based on nanometer-sized carbon material developed by a consortium of Rice labs led by chemist James Tour and is the subject of a new paper published this month in the American Chemical Society journal ACS Applied Materials and Interfaces. Limited exposure to hydrogen sulfide causes sore throats, shortness of breath and dizziness, according to the researchers. ...

New research focuses on streamwater chemistry, landscape variation

2014-04-22

MISSOULA – Winsor Lowe, interim director of the University of Montana's Wildlife Biology Program, co-wrote a research paper published April 21 in the Proceedings of the National Academy of Sciences on how streamwater chemistry varies across a headwater stream network. Lowe and co-authors from Virginia Tech, the U.S. Geological Survey, the University of Washington, the Cary Institute of Ecosystem Studies, the University of Connecticut and the U.S. Forest Service Northern Research Station examined 664 water samples collected every 10 meters along 32 tributaries ...

Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: